ll1in-labelled platelets for assessment of thrombogenicity of new haemodialysis vascular access

Nuclear Medicine Communications

Volumn 20, Issue 5, 1999, Pages 445-452

  Neumann, I ^a   Meisl, F T ^b   Kopriva, G ^b   Manker, W ^b   Sinzinger, H ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b WILHELMINEN HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

INDIUM 111; DIAGNOSTIC AGENT; INDIUM;

ADULT; AGED; ARTERIOVENOUS SHUNT; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; BLOOD VESSEL GRAFT; CELL LABELING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOPPLER FLOWMETRY; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; IMAGE ANALYSIS; ISOTOPE LABELING; MALE; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOSIS; VASCULAR ACCESS; ARTERIOVENOUS FISTULA; FOLLOW UP; INDWELLING CATHETER; INSTRUMENTATION; MIDDLE AGED; RENAL REPLACEMENT THERAPY; SCINTISCANNING; TIME;

ADULT; AGED; AGED, 80 AND OVER; ARTERIOVENOUS FISTULA; BLOOD PLATELETS; BLOOD PRESSURE; CATHETERS, INDWELLING; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDIUM RADIOISOTOPES; MALE; MIDDLE AGED; RENAL DIALYSIS; THROMBOSIS; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER;

EID: 0033129568     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199905000-00008     Document Type: Article

References (25)

1. Davis HH, Siegel BA, Welch MJ. Scintigraphic detection of an arterial thrombosis with In-lll-labeled autologous platelets. J Nucl Med 1980; 21: 548-549.
2. Goodwin DA, Bushberg JT, Dothery PW et al. Indium-ill-labeled autologous platelets for localisation of vascular thrombi in humans. J Nucl Med 1978; 19: 626-634.
3. Grossman ZD, Wistow BW, McAfee JG et al. Platelets labeled with oxine complexes of Tc-99m and In-111: Localizations of experimentally induced vascular lesions. J Nucl Med 1978; 19: 488-491.
4. Kessler C, Henningson H, Reuther R, Kimming B, Rosch M. Identification of intracardiac thrombi in stroke patients with indium 111-platelet scintigraphy. Stroke 1987; 18: 63-67.
5. Thakur ML, Welch MJ, Joist JH, Coleman RE. Indium-111 labeled platelets: Studies on preparation and evaluation of in vitro and in vivo functions. Thromb Res 1976; 9: 345-357.
6. Davis HH, Siegel BA, Joist JH et al. Scintigraphic detection of atherosclerotic lesions and venous thrombi in man by indium-ill-labelled autologous platelets. Lancet 1978; 1: 1185-1187.
7. Davis HH, Siegel BA, Sherman LA et al. Scintigraphic detection of carotid atherosclerosis with indium-111-labeled autologous platelets. Circulation 1980; 61: 982-988.
8. Dewanjee MK, Kapadvanjwala M, Ruzius K, Serafini AN, Zilleruelo GE, Sfakianakis GN. Quantitation of thrombo-genicity of hemodialyzer with technetium-99m and indium-111 labeled platelets. Nucl Med Biol 1993; 20: 579-587.
9. Dewanjee MK, Kapadvanjwala M, Cavagnaro CF et al. In vitro and in vivo evaluation of the comparative thrombo-genicity of cellulose acetate hemodialyzers with radio-labeled platelets. ASAIO 1994; 40: 49-55.
10. Windus DW, Santoro S, Royal HD. The effects of hemodialysis on platelet deposition in prosthetic graft fistulas. Am J Kidney Dis 1995; 26: 614-621.
11. Remuzzi G, Pusineri F. The uremic platelet. In: Remuzzi G, Rossi E, eds. Haemostasis and the kidney. London: Butter-worths, 1998: 107-118.
12. Gafter U, Bessler H, Malachi T, Zevin D, Djaldetti M, Levi J. Platelet count and thrombopoietic activity in patients with chronic renal failure. Nephron 1987; 10: 180-186.
13. Steward JH. Platelet numbers and lifespan in acute and chronic renal failure. Thromb Diath Haemorrh 1967; 17: 532-542.
14. Callow AD, Ledig CB, O’Donnell T et al. A primate model for the study of the interaction of 111-In-labeled baboon platelets with Darcon arterial prostheses. Ann Surg 1980; 19: 362-366.
15. Kherlakain GM, Roedersheimer LR, Arbaugh JJ, Newmark KL, King LR. Comparison of autogenous fistula versus expanded polytetrafluoroethylene graft fistula for angio-access in hemodialysis. Am J Surg 1986; 152: 238-243.
16. Zibary GB, Rohr MS, Landreneau MD et al. Complications from permanent hemodialysis vascular access. Surgery 1988; 104: 681-686.
17. Fuster V, Dewanjee MK et al. Noninvasive radioisotope technique for detection of platelet deposition in coronary artery bypass grafts in dogs and its reduction with platelet inhibitors. Circulation 1979; 60: 1508-1512.
18. Pumphery CW, Chesebro JH, Dewanjee MK et al. In vivo quantitation of platelet deposition on human peripheral arterial bypass grafts using indium-lll-labeled platelets: Effect of dipyridamole and aspirin. Am J Cardiol 1983; 51: 796-801.
19. Ritchie JL, Lindner A, Hamilton GW, Harker LA. 111-In-oxine imaging in hemodialysis patients: Detection of platelet deposition at vascular access sites. Nephron 1982; 31: 333-336.
20. Diskin CJ, Stokes TJ, Pennell AT. Pharmacologic intervention to prevent hemodialysis vascular access thrombosis. Nephron 1993; 64: 1-26.
21. Douglass TD, Joan E, Bauman JE, Joist H. Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis. Thromb Res 1991; 62: 737-743.
22. Sreedhara R, Himmelfarb J, Lazarus JM, Hakim RM. Antiplatelet therapy in graft thrombosis: Results of a randomized, double-blind study. Kidney Int 1994; 45: 1477-1483.
23. Koksoy C, Kuzu A, Erden I, Tiirkcapar AG, Diizgiin I, Anadol E. Predictive value of Doppler ultrasonography in detecting failure of vascular access grafts. Br J Surg 1995; 82: 50-52.
24. Shackleton CR, Taylor DC, Buckley AR, Rowley VA, Cooperberg PL, Fry PD. Predicting failure in polytetrafluoroethylene vascular access grafts for hemodialysis: A pilot study. Can J Surg 1987; 30: 442-444.
25. Sinzinger H, Kolbe H, Strobl-Jager E, Hofer R. A simple and safe technique for sterile autologous platelet labelling using ’Monovette’ vials. Eur Nucl Med 1984; 9: 320-322.